Leveraged buyouts, growth capital, angel investments, and seed funding—these private transactions take place, largely out of the public’s eye, not only in Connecticut or Silicon Valley, but also in Beijing, Shenzhen, and Shanghai.
In 2016, China’s private equity (PE) and venture capital (VC) firms raised over $70 billion, more than 20% of total such funding globally. At the same time, these firms also deployed capital to the tune of $223 billion, accounting for more than 70% of global PE/VC investments.
As late comers, these Chinese firms have rapidly grown into formidable financiers. Most Chinese PE firms are particularly interested in products and services that can be commercialized and scaled up quickly in China. They tend to invest in areas that align with China’s shift to a more consumer-driven economy. Meanwhile, Chinese VCs have been active players globally, particularly in Silicon Valley. They have focused on areas such as artificial intelligence, Internet of Things, and electric vehicles.
Legend Capital is a venture capital (VC) subsidiary under its parent Legend Holdings. The VC firm specializes in early-stage and growth capital investments that are relevant to the Chinese economy. It manages several USD- and RMB-denominated funds with more than ¥30 billion ($5 billion) assets under management. Some of its investments that have recently exited through initial public offerings include Auto Navi, Renren.com, Spread Trum, and Vance Info.
Linan Zhu
Beijing: (010) 8913.9000
master@legendcapital.com.cn
In June 2014, Legend Capital, along with Founders Fund, Formation 8, and GGV Capital, co-led a series C $50 million investment in Wish, a mobile shopping app. In November 2014, Legend Capital led a Series C $53 million investment in the San Diego-based biotech company, BioNano, which specializes in advance genomic mapping technology to reach the “inaccessible genome."
In March 2014, Legend Capital, along with NeoMed Management, participated in an Edmond de Rothschild Investment Partners-led Series A funding of $33 million in Axonics Modulation Technologies. Axonics is an Irvine, CA-based medical device company that develops novel implantable neuromodulation technology.